Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01981837
Brief Title: Phase 2 Study to Evaluate ALN-TTRSC (Revusiran) in Patients With Transthyretin (TTR) Cardiac Amyloidosis

First Submitted : November 6, 2013
First Submitted that Met QC Criteria : November 6, 2013
First Posted : November 13, 2013 (Estimate)

Certification/Extension First Submitted : January 24, 2018
Certification/Extension First Submitted that Met QC Criteria : January 26, 2018
Certification/Extension First Posted : January 29, 2018

Last Update Submitted that Met QC Criteria : January 26, 2018
Last Update Posted : January 29, 2018